Irish tax-registered pharmaceutical
Amgen quarterly profit rises 15%, obesity drug trials are on track: Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase ...
reut.rs/3HRMKJ4
Amgen (AMGN) Sees 2024 Revenue Jump After Horizon Therapeutics Purchase: Amgen Inc. expects revenue to jump as much as 20% this year, as the purchase of Horizon ...
bloomberg.com/news/articles/2024-02-06/amgen-expects-a-2024-sales-jump-sets-sights-on-obesity-market
Novo Nordisk: The next deals - Partner's share explodes: The Danish pharmaceutical giant tends to shy away from larger takeovers.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-die-naechsten-deals-aktie-von-partner-explodiert-20346898.html
US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision: Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the U ...
reuters.com/markets/deals/us-senator-elizabeth-warren-expresses-disappointment-ftcs-amgen-decision-2023-11-09/
Amgen sales rise, but shares off as investors await obesity data: Amgen (AMGN.O) on Tuesday said third-quarter sales rose 5%, but a full-year sales forecast ...
reuters.com/business/healthcare-pharmaceuticals/amgen-third-quarter-sales-rise-5-profit-up-before-charge-2023-10-31/
Former Horizon Therapeutics CEO Tim Walbert was the buyer who paid $13.5M for Lake Geneva mansion
chicagotribune.com/real-estate/elite-street/ct-re-elite-street-time-walbert-lake-geneva-20231111-x33mmp7hefgj3mam3dlx37kq4y-story.html
Quick Glance: Former CEO Buys $13.5M Lake Geneva Property
- Timothy P. Walbert, former CEO of Horizon Therapeutics, and his wife Keli purchased an 8,756-square-foot property on the southern shoreline of Geneva Lake in Lake Geneva, Wisconsin, in June for $13.5 million.
- The property was built in 2018 and designed by the architectural firm Morgante Wilson Architects. In June, they paid $13.5 million for the property.
- The Walberts acquired the property from John Cobb, the recently retired Chief Investment Officer of Chicago-based real estate investment trust Ventas Inc., and his wife Sarah.
- The Walberts’ new property was not publicly listed, but the Cobbs had privately offered it for sale in April, and in June, the Walberts paid $13.5 million.
Amgen Raises Revenue Guidance After Closing Horizon Purchase: Amgen Inc. raised its full-year revenue guidance after closing the purchase of rare-disease ...
bloomberg.com/news/articles/2023-10-31/amgen-raises-revenue-guidance-after-closing-horizon-purchase
Amgen to Lay Off 350 Horizon Employees After Closing $27.8 Billion Deal: Amgen Inc. will lay off 350 employees from Horizon Therapeutics Plc next year ...
bloomberg.com/news/articles/2023-10-24/amgen-to-cut-350-horizon-employees-after-closing-purchase
Amgen completes $27.8 billion Horizon deal: Amgen (AMGN.O) said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics (HZNP ...
reuters.com/markets/deals/amgen-completes-278-bln-horizon-deal-2023-10-06/
Amgen’s plans for €1bn Waterford campus in doubt: The US biotech giant says it will evaluate options following completion of €26 billion takeover of Horizon
businesspost.ie/news/amgens-plans-for-e1bn-waterford-campus-in-doubt/
Amgen’s $27.8 Billion Horizon Takeover Allowed in FTC Accord: Amgen Inc. can move forward with its $27.8 billion takeover of Horizon Therapeutics Plc after the ...
bloomberg.com/news/articles/2023-09-01/amgen-reaches-settlement-with-ftc-on-27-8-billion-horizon-deal
Analysis: FTC settlement could shelter Amgen from US price cuts, taxes: The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of ...
reuters.com/business/healthcare-pharmaceuticals/ftc-settlement-could-shelter-amgen-us-price-cuts-taxes-2023-09-05/
Odds of Amgen-Horizon Deal Closing Rise to 90%, According to WallachBeth: Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover ...
bloomberg.com/news/articles/2023-08-28/amgen-horizon-deal-seen-close-to-a-lock-as-ftc-pauses-challenge
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
reuters.com/markets/deals/us-ftc-suspends-challenge-block-amgens-278-bln-deal-horizon-therapeutics-2023-08-26/
Best Dividend Stocks: Amgen Hits Buy Point, Offers Solid Dividend Growth: Dividend stock Amgen's five-year dividend growth rate of 10.2% is impressive.
investors.com/research/the-income-investor/dividend-stocks-amgen-outperforms-hitting-buypoint-offers-solid-dividend-growth/
US Watchdog approves Amgen’s deal: The Federal Trade Commission, or FTC, has given its approval for Amgen's ambitious 27.8 billion dollar purchase of horizon ...
wionews.com/videos/us-watchdog-approves-amgens-deal-632116
The Federal Trade Commission has given its approval for Amgen's ambitious $27.8 billion purchase of Horizon Therapeutics.
@esha_hanspal tells you more
Watch ... Show more wionews.com/videos
Horizon Therapeutics (HZNP) Jumps On A New #FTC Development In The Amgen Takeover Battle
investors.com/news/technology/hznp-stock-jumps-on-a-new-ftc-development-in-the-amgen-takeover-battle/
FTC Says No Ongoing Talks to Resolve Blocked $27.8 Billion Amgen-Horizon Deal: The Federal Trade Commission said that there are no ongoing talks with Amgen Inc ...
bloomberg.com/news/articles/2023-07-19/ftc-says-amgen-horizon-deal-block-settlement-talks-have-ended
California, other states join FTC bid to block Amgen deal: The states of California, New York, Illinois, Minnesota, Washington and Wisconsin have joined a ...
reuters.com/markets/deals/california-other-states-join-ftc-bid-block-amgen-deal-2023-06-22/
Eli Lilly boosts immunology business with $2.4 billion deal for Dice: Eli Lilly and Co (LLY.N) will buy Dice Therapeutics Inc (DICE.O) for about $2 ...
reuters.com/markets/deals/eli-lilly-buy-dice-therapeutics-24-billion-deal-2023-06-20/
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics: The Federal Trade Commission said the deal would enable Amgen to exploit its size to ...
nytimes.com/2023/05/16/business/amgen-horizon-therapeutics-lawsuit.html
Amgen agrees not to seek quick close to Horizon acquisition: Amgen Inc (AMGN.O) has agreed not to quickly close on its $27.8 billion acquisition of Horizon ...
reuters.com/legal/us-court-issues-temporary-restraining-order-278-bln-amgen-horizon-deal-2023-05-18/
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears: Investors are scrambling to assess the fallout of a U.S. regulatory challenge against ...
reuters.com/markets/deals/amgens-antitrust-woes-spur-wider-pharmaceutical-deal-fears-2023-05-17/
High drug prices: Horizon sale on the brink: Amgen's nearly $28 billion purchase of Horizon Therapeutics is on the brink. If the transaction fails ...
nzz.ch/wirtschaft/die-us-kartellbehoerde-zeigt-ihre-zaehne-milliardenschwere-akquisitionen-werden-fuer-pharmafirmen-schwieriger-ld.1738768
A more aggressive FTC is starting to target drug mergers and industry middlemen: An FTC lawsuit against the Amgen-Horizon merger raises issues about PBMs’ role ...
usatoday.com/story/news/health/2023/05/21/ftc-targets-amgen-horizon-drug-mergers-pbms/70237166007/
Vincent Boland: US regulator’s shot across bows of Amgen/Horizon deal leaves big pharma reeling
businesspost.ie/article/vincent-boland-us-regulators-shot-across-bows-of-amgen-horizon-deal-leaves-big-pharma-reeling/
US Challenge to Amgen Deal Threatens Big Pharma Business Model: US trade regulators’ surprise attempt to block a pending drug industry merger is creating alarm ...
bloomberg.com/news/articles/2023-05-16/ftc-challenge-to-amgen-amgn-horizon-deal-threatens-big-pharma-business-model
FTC Poised to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics: The FTC is preparing to seek an injunction in federal court that would prevent the deal ...
wsj.com/articles/ftc-poised-to-block-amgens-27-8-billion-deal-for-horizon-therapeutics-a9c1b499
Wells Fargo says this little-known biotech company could rally more than 80%: Analyst Derek Archila said shares of Viridian Therapeutics have more than 80% ...
cnbc.com/2023/04/17/wells-fargo-says-little-known-biotech-stock-could-rally-more-than-80percent.html
Soros Fund adds First Horizon, Horizon Therapeutics and bond ETF: Soros Fund Management, the family office of billionaire George Soros, added to its portfolio ...
reuters.com/markets/wealth/soros-fund-adds-first-horizon-horizon-therapeutics-bond-etf-2023-02-14/
Amgen to scale back plan for €1bn Waterford campus: US biotech company will not need the large campus proposed by Horizon, which it is in the process of ...
businesspost.ie/news/amgen-to-scale-back-plan-for-e1bn-waterford-campus/
Amgen revenue falls slightly as Lilly COVID deal contributes less: Amgen Inc (AMGN.O) on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase ...
reuters.com/business/healthcare-pharmaceuticals/amgen-revenue-falls-slightly-lilly-covid-deal-contributes-less-2023-01-31/
U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals: Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S ...
reuters.com/markets/deals/warren-tells-ftc-she-is-particularly-concerned-about-amgen-indivior-deals-2023-01-26/
Amgen Kicks Off Jumbo Dollar Bond Deal to Finance Horizon Acquisition: Amgen Inc. is selling a $24 billion investment-grade bond Wednesday to help fund its ...
bloomberg.com/news/articles/2023-02-15/amgen-kicks-off-jumbo-dollar-bond-sale-to-fund-horizon-purchase
Health-care stocks are looking good for 2023 and not just because the sector is a 'safe haven'
cnbc.com/2022/12/21/health-care-stocks-2023-big-pharma-still-favored-but-good-bets-in-biotech-are-out-there.html
Amgen’s $28 bln deal is a reasonable gamble: Biotechnology deals are always a gamble, and, on the face of it, Amgen’s (AMGN.O) $28 billion purchase of Horizon ...
reuters.com/breakingviews/amgens-28-bln-deal-is-reasonable-gamble-2022-12-12/
Deal Making Will Rebound in 2023: Economic conditions won’t be ideal next year, but executives will have more confidence in making acquisitions.
barrons.com/articles/deal-making-rebound-2023-51671221859
Amgen’s $28 bln deal is a reasonable gamble: Biotechnology deals are always a gamble, and, on the face of it, Amgen’s (AMGN.O) $28 billion purchase of Horizon ...
reuters.com/breakingviews/amgens-28-bln-deal-is-reasonable-gamble-2022-12-12/
Amgen emerges frontrunner in Horizon deal as Sanofi drops bid: Amgen Inc (AMGN.O) is in advanced talks to buy biotech company Horizon Therapeutics Plc (HZNP.O) ...
reuters.com/markets/deals/sanofi-says-it-does-not-intend-make-an-offer-horizon-2022-12-11/
J&J unit says does not intend to bid for Horizon Therapeutics: Johnson & Johnson (JNJ.N) unit Janssen Global Services said on Saturday that it does not intend to ...
reuters.com/markets/deals/jj-unit-says-does-not-intend-bid-horizon-therapeutics-2022-12-03/
Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi: Horizon Therapeutics Plc (HZNP.O) said on Tuesday its board was engaged in highly ...
reuters.com/markets/deals/horizon-therapeutics-fields-buyout-interest-amgen-jj-sanofi-2022-11-29/
Jim Cramer says three key deals helped the market rally on Monday: Stocks rose on Monday ahead of the monthly consumer price index report set to release Tuesday ...
cnbc.com/2022/12/12/jim-cramer-says-three-key-deals-helped-the-market-rally-on-monday.html
Sanofi says any offer for Horizon Therapeutics, if made, will be in cash: French drugmaker Sanofi (SASY.PA) said on Friday that if it decides to bid for biotech ...
reuters.com/markets/deals/french-company-sanofi-any-offer-horizon-therapeutics-if-made-will-be-cash-2022-12-02/
Horizon gets green light for €1bn biopharma factory: Global pharma firm Horizon Therapeutics has received planning permission to develop Waterford ...
businesspost.ie/news/horizon-gets-green-light-for-e1bn-biopharma-factory/
Amgen to buy drugmaker Horizon Therapeutics in US$26.4-billion deal : Amgen said Monday that it will pay $116.50 in cash for each share of Horizon ...
theglobeandmail.com/business/international-business/article-amgen-to-buy-drugmaker-horizon-therapeutics-in-us264-billion-deal/
Amgen Hunts for New Revenue in $28 Billion Deal: The purchase of Horizon brings in rare-disease drugs with billions of dollars in sales that could offset revenue ...
wsj.com/articles/amgen-hunts-for-new-revenue-in-28-billion-deal-11670876663
Amgen Agrees to Deal to Buy Horizon Therapeutics: The U.S. biotechnology company will pay $116.50 for each Horizon share
wsj.com/articles/amgen-in-advanced-talks-to-buy-horizon-therapeutics-11670785882
John Paulson to rake in $500 million from Amgen's buyout of Horizon: Horizon is the largest disclosed holding of John Paulson's family office Paulson & Co. ...
markets.businessinsider.com/news/stocks/john-paulson-investing-amgen-horizon-merger-500-million-biotech-subprime-2022-12
Horizon Therapeutics to be acquired in $28 billion deal, throwing future of Deerfield offices into question
chicagotribune.com/business/ct-biz-amgen-acquiring-horizon-pharmaceuticals-20221212-a3vorjyiczexlfiuypsbbszfuq-story.html
This biotech stock soared 20% last week — and analysts are giving it another 36% upside
cnbc.com/2022/11/07/this-biotech-stock-soared-20percent-last-week-and-analysts-give-36percent-upside.html
Billion dollar poker: Johnson & Johnson exits: Several large companies have expressed interest in acquiring biopharmaceutical company Horizon Therapeutics.
deraktionaer.de/artikel/pharma-biotech/milliarden-dollar-poker-johnson-johnson-steigt-aus-20322244.html
Drug company Horizon Therapeutics confirms it is in talks with potential suitors: Horizon confirmed the discussions Tuesday in a news release
chicagotribune.com/business/ct-biz-horizon-therapeutics-for-sale-discussions-20221129-6mzknesed5dppmwuvedpfsui54-story.html
Canadian drug pricing regulator issues record drug pricing fine: The Patented Medicine Prices Review Board announces that it had ordered Horizon Pharma to pay ...
theglobeandmail.com/canada/article-canadian-drug-pricing-regulator-issues-record-drug-pricing-fine/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics